retatrutide phase 2 trial weight loss clinical trials results New 3 data just dropped 👀 Eli Lilly's retatrutide type 2 diabetes phase

Key protective strategies include: Pre-treatment ophthalmologic evaluation : Establish baseline retinal status before initiating GLP-1 therapy, particularly in patients with diabetes duration exceeding 10 years or poor prior glycemic control Individualized medication titration : Consider a more gradual dose escalation approach to avoid precipitous drops in blood glucose for patients with advanced diabetic retinopathy, in coordination with ophthalmology care Appropriate monitoring : Discuss with your healthcare provider whether more frequent eye examinations are needed based on your individual risk factors and baseline retinal status Prompt reporting of visual symptoms : Contact your healthcare provider immediately if you experience sudden vision loss, new or dense floaters, flashing lights, a "curtain" over your vision, eye pain with vision changes, or any sudden vision disturbance Patients without pre-existing diabetic retinopathy can generally follow standard eye examination schedules and do not require additional ophthalmologic monitoring solely due to GLP-1 use

Antioxidants (2021) 10:201

It's supposed to be the gentlest on the stomach, and I've had minimal issues except for when I eat something greasy or fatty

But what exactly is the mechanism underlying CSF1Ri-mediated microglial depletion

These preparations allow for customized dosing and can be a vital resource when branded options are unavailable